Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

With the US obesity rate hovering at around 40%, tens of millions of Americans could take GLP-1 drugs over the next few years ...

When it comes to losing weight, Al Roker is the last person to judge Ozempic users and give anyone insight into reaching the ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Norvo Nordisk, a global healthcare company, is currently involved in a product liability lawsuit against its Ozempic brand, a ...

The study found that semaglutide, sold under brand names Ozempic and Wegovy reduced the hospitalization risk by 22% in alcoholic patients. Ozempic had earlier been shown to mitigate joint pain.

Ozempic, a popular weight-loss drug, has helped many shed pounds and improve their health. However, discontinuing the ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...